Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Psychiatry|March 30, 2019
Posttraumatic Stress Disorder and Neurocognitive Impairment in a U.S. Military Cohort of Persons Living with HIVRobert Deiss, Cdr Justin Campbell, Caitlin Wei-Ming Watson, et al.
Drug and Alcohol Dependence|February 11, 2014
Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatmentSaurabh Gupta, Jennifer E Iudicello, Chuan Shi, et al.
AIDS (London, England)|December 3, 2019
Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapyLisa J Henderson, Tory P Johnson, Bryan R Smith, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Journal of Neurovirology|March 2, 2017
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case studySergio M de Almeida, Indianara Rotta, Clea E Ribeiro, et al.
Neurobiology of Disease|June 26, 2019
Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astrogliaMary K Swinton, Aliyah Carson, Francesca Telese, et al.
Viruses|August 10, 2021
The Relationships between HIV-1 Infection, History of Methamphetamine Use Disorder, and Soluble Biomarkers in Blood and Cerebrospinal FluidT Jordan Walter, Jennifer Iudicello, Debra Rosario Cookson, et al.
Msystems|October 14, 2020
Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCVBryn C Taylor, Kelly C Weldon, Ronald J Ellis, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorderRonald J Ellis, Scott Letendre, Florin Vaida, et al.
Pageof 19